KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Intangibles for 4 consecutive years, with $100.2 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Intangibles changed N/A year-over-year to $100.2 million, compared with a TTM value of $100.2 million through Sep 2023, changed N/A, and an annual FY2022 reading of $111.0 million, up 413.08% over the prior year.
  • Intangibles was $100.2 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $111.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $111.0 million in Q4 2022 and bottomed at $3.3 million in Q4 2020.
  • Average Intangibles over 4 years is $51.7 million, with a median of $22.6 million recorded in 2021.
  • The sharpest move saw Intangibles surged 557.01% in 2021, then surged 413.08% in 2022.
  • Year by year, Intangibles stood at $3.3 million in 2020, then soared by 557.01% to $21.6 million in 2021, then soared by 413.08% to $111.0 million in 2022, then dropped by 9.79% to $100.2 million in 2023.
  • Business Quant data shows Intangibles for DNA at $100.2 million in Q3 2023, $111.0 million in Q4 2022, and $21.6 million in Q4 2021.